Skip to main content
Top
Published in: Cancer Causes & Control 3/2018

01-03-2018 | Commentary

Geospatial approaches to cancer control and population sciences at the United States cancer centers

Authors: Robert W. Korycinski, Bethany L. Tennant, Michelle A. Cawley, Bonny Bloodgood, April Y. Oh, David Berrigan

Published in: Cancer Causes & Control | Issue 3/2018

Login to get access

Abstract

Purpose

Geospatial, contextual, and multilevel research is integral to cancer prevention and control. NCI-designated Cancer Centers are at the forefront of cancer research; therefore, this paper sought to review the geospatial, contextual, and multilevel research at these cancer centers.

Methods

Investigators used PubMed and Web of Science to compile geospatial publications from 1971 to February 2016 with cancer center-affiliated authors. Relevant abstracts were pulled and classified by six geospatial approaches, eight geospatial scales, and eight cancer sites.

Results

The searches identified 802 geospatial, contextual, and multilevel publications with authors affiliated at 60 of the 68 NCI-designated Cancer Centers. Over 90% were published after 2000. Five cancer centers accounted for approximately 50% of total publications, and 30 cancer centers accounted for over 85% of total publications. Publications covered all geospatial approaches and scales to varying degrees, and 90% dealt with cancer.

Conclusions

The NCI-designated Cancer Center network is increasingly pursuing geospatial, contextual, and multilevel cancer research, although many cancer centers still conduct limited to no research in this area. Expanding geospatial efforts to research programs across all cancer centers will further enrich cancer prevention and control. Similar reviews may benefit other domestic and international cancer research institutions.
Appendix
Available only for authorised users
Literature
3.
go back to reference Krieger N, Chen JT, Waterman PD, Soobader MJ, Subramanian SV, Carson R (2002) Geocoding and monitoring of US socioeconomic inequalities in mortality and cancer incidence: does the choice of area-based measure and geographic level matter?: the Public Health Disparities Geocoding Project. Am J Epidemiol 156:471–482. https://doi.org/10.1093/aje/kwf068 CrossRefPubMed Krieger N, Chen JT, Waterman PD, Soobader MJ, Subramanian SV, Carson R (2002) Geocoding and monitoring of US socioeconomic inequalities in mortality and cancer incidence: does the choice of area-based measure and geographic level matter?: the Public Health Disparities Geocoding Project. Am J Epidemiol 156:471–482. https://​doi.​org/​10.​1093/​aje/​kwf068 CrossRefPubMed
4.
go back to reference Burbank F (1971) Patterns in cancer mortality in the United States: 1950–1967. Natl Cancer Inst Monogr 71:1–594PubMed Burbank F (1971) Patterns in cancer mortality in the United States: 1950–1967. Natl Cancer Inst Monogr 71:1–594PubMed
20.
go back to reference Eberth JM, Zhang X, Hossain M, Tiro JA, Holt JB, Vernon SW (2013) County-level estimates of human papillomavirus vaccine coverage among young adult women in Texas, 2008. Tex Public Health J 65:37–40PubMedPubMedCentral Eberth JM, Zhang X, Hossain M, Tiro JA, Holt JB, Vernon SW (2013) County-level estimates of human papillomavirus vaccine coverage among young adult women in Texas, 2008. Tex Public Health J 65:37–40PubMedPubMedCentral
Metadata
Title
Geospatial approaches to cancer control and population sciences at the United States cancer centers
Authors
Robert W. Korycinski
Bethany L. Tennant
Michelle A. Cawley
Bonny Bloodgood
April Y. Oh
David Berrigan
Publication date
01-03-2018
Publisher
Springer International Publishing
Published in
Cancer Causes & Control / Issue 3/2018
Print ISSN: 0957-5243
Electronic ISSN: 1573-7225
DOI
https://doi.org/10.1007/s10552-018-1009-0

Other articles of this Issue 3/2018

Cancer Causes & Control 3/2018 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine